Nutex Health Q2 net income $65.8M vs loss $17.7M YoY; revenue down 13.6%

Nutex Health Inc.

2026-Q2 EPS reported $15.87 revenue$427,237,000

Diluted EPS $9.38 vs $(2.95) in Q2 2025; six-month net income $112.6M, EPS $15.87.
Revenue $210.8M (-13.6% YoY) due to prior-year IDR benefits; hospital visits +9.6%.
Adjusted EBITDA $90.0M vs $71.6M; operating cash flow $34.2M vs $27.3M.
HaloMD amendment and CMS fee cut reduced contract services by $52.3M; expects 25-30% ongoing savings.
Cash $205.2M, long-term debt $31.1M; three new hospitals expected to open in H2 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.